These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29745323)

  • 1. Research Progress on Brucellosis.
    Deng Y; Liu X; Duan K; Peng Q
    Curr Med Chem; 2019; 26(30):5598-5608. PubMed ID: 29745323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cross-Protective Potential Antigens against Pathogenic
    Hisham Y; Ashhab Y
    J Immunol Res; 2018; 2018():1474517. PubMed ID: 30622973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis.
    Edmonds MD; Cloeckaert A; Elzer PH
    Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
    Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
    Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucella vaccines in wildlife.
    Davis DS; Elzer PH
    Vet Microbiol; 2002 Dec; 90(1-4):533-44. PubMed ID: 12414169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of clinical and laboratory features of human brucellosis.
    Mantur BG; Amarnath SK; Shinde RS
    Indian J Med Microbiol; 2007 Jul; 25(3):188-202. PubMed ID: 17901634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brucellosis in humans--etiology, diagnostics, clinical forms.
    Galińska EM; Zagórski J
    Ann Agric Environ Med; 2013; 20(2):233-8. PubMed ID: 23772567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.
    Godfroid J; Cloeckaert A; Liautard JP; Kohler S; Fretin D; Walravens K; Garin-Bastuji B; Letesson JJ
    Vet Res; 2005; 36(3):313-26. PubMed ID: 15845228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella species-induced brucellosis: Antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles.
    Elbehiry A; Aldubaib M; Al Rugaie O; Marzouk E; Moussa I; El-Husseiny M; Ibrahem M; Abalkhail A; Rawway M
    PLoS One; 2022; 17(7):e0269963. PubMed ID: 35834538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus.
    Díaz Aparicio E
    Rev Sci Tech; 2013 Apr; 32(1):43-51, 53-60. PubMed ID: 23837364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
    Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
    Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of B. melitensis Rev. 1 and B. abortus strain 19 as a vaccine against brucellosis in cattle.
    García-Carrillo C
    Zentralbl Veterinarmed B; 1980; 27(2):131-8. PubMed ID: 6781179
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella: a Mr "Hide" converted into Dr Jekyll.
    Gorvel JP
    Microbes Infect; 2008 Jul; 10(9):1010-3. PubMed ID: 18664389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucellosis: an overview.
    Corbel MJ
    Emerg Infect Dis; 1997; 3(2):213-21. PubMed ID: 9204307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.